All Cases

458 cases · 248 approved / sustained · 207 denied / dismissed · 3 remanded

Researcher

Healthcare

WeGreened EB-2 (NIW) approved
3 days 2026-03-02
The petitioner proposes to combine advanced clinical training with research to improve minimally invasive and reconstructive approaches for complex facial and nerve injuries. The work focuses on reducing downstream functional impairment and the overall care burden for patients.
View Case

Doctor

Healthcare · South Korea

WeGreened EB-2 (NIW) rfe approved
224 days 2026-01-31
The petitioner proposes to develop innovative medical devices for heart and lung diseases by integrating device hardware, AI-driven interpretation, and digital health delivery. The work focuses on systems that collect physiological signals and use advanced algorithms to extract clinically relevant patterns to improve patient outcomes and reduce healthcare costs.
View Case

Research Assistant

Healthcare · China

WeGreened EB-2 (NIW) approved
California 30 days 2026-01-30
The petitioner proposes to use large-scale population datasets, cancer registries, and modern modeling tools, including AI, to identify healthcare and biological determinants of cancer outcomes and disparities. Her work focuses on building statistical and computational frameworks that connect real-world data to clinical decisions, specifically identifying barriers to delayed diagnosis and gaps in care. The goal is to translate these findings into evidence-based strategies for cancer prevention, early detection, and survivorship care.
View Case

Epidemiologist

Healthcare · Sri Lanka

WeGreened EB-2 (NIW) approved
North Carolina 66 days 2026-01-26
The petitioner proposes to develop comprehensive public health strategies for the surveillance, prevention, and control of vectors and vector-borne diseases. Her work integrates molecular diagnostics, spatial epidemiology, and data-driven analysis to strengthen preparedness against diseases such as Lyme disease and Rocky Mountain spotted fever.
View Case

Doctor

Healthcare · Canada

WeGreened EB-2 (NIW) approved
96 days 2026-01-23
The petitioner proposes to generate rigorous evidence to improve how the United States prevents, diagnoses, and manages emerging and complex infectious diseases. The work focuses on developing health-system infrastructure and evidence-based infection prevention protocols to guide treatment decisions and improve readiness for healthcare-associated threats.
View Case

Physician

Healthcare

WeGreened EB-2 (NIW) approved
U.S.-based healthcare environment 46 days 2026-01-17
The petitioner proposes to collect and analyze data from cancer research studies to assess the efficacy and complications of cancer therapies. This work aims to strengthen evidence-based treatment decisions and improve real-world outcomes for patients by characterizing adverse effects that may compromise quality of life.
View Case

Others

Healthcare · Kenya

WeGreened EB-2 (NIW) approved
Missouri 398 days 2026-01-17
The petitioner proposes to design interventions and programs that leverage health communication strategies to promote mental health resilience among youth in the United States. The work focuses on reducing health stigma among marginalized populations and enhancing mental well-being and inclusivity through communication-driven prevention resources.
View Case

Postdoctoral Researcher

Healthcare · Taiwan

WeGreened EB-2 (NIW) approved
Texas 304 days 2026-01-16
The petitioner proposes to continue research in the field of magnetic resonance imaging, specifically focusing on advanced imaging techniques for medical applications. The work involves developing innovative hyperpolarized carbon-13 MRI methods to enable early detection and precise imaging of cardiovascular and neurodegenerative diseases. This endeavor aims to enhance diagnostic accuracy, optimize clinical workflows, and improve patient outcomes in the U.S. healthcare system.
View Case

Others

Healthcare · Pakistan

WeGreened EB-2 (NIW) approved
Pennsylvania 56 days 2026-01-12
The petitioner proposes to conduct retrospective and prospective studies in clinical medicine and rheumatology to enable earlier diagnosis and treatment of complex diseases. The work specifically investigates manifestations such as Melanoma differentiation-associated protein 5 (MDA5) to improve patient outcomes and refine therapeutic protocols for severe autoimmune disorders.
View Case

Doctor

Healthcare · India

WeGreened EB-2 (NIW) approved
California 84 days 2026-01-09
The petitioner proposes to continue her research in breast oncology, specifically identifying genomic markers and tumor microenvironmental determinants to manage breast cancer progression. Her work focuses on distinguishing between high-risk patients requiring immediate intervention and low-risk patients suitable for non-surgical watchful waiting. This research aims to facilitate new immune-based treatments and reduce the burden of unnecessary surgeries in the U.S. healthcare system.
View Case